13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuropharmacology and Novel Drug Development
The field of neuropharmacology and novel drug development delves into the biochemical pathways and molecular targets underlying neurological function and dysfunction. This research area is pivotal in driving the creation of innovative drugs, ranging from neuroprotective agents to neuromodulators. Advanced methodologies, such as CRISPR-based genome editing and nanotechnology, are transforming the delivery and effectiveness of neurotherapeutics. Researchers are also focusing on strategies to overcome the challenges of the blood-brain barrier, ensuring enhanced drug delivery to the central nervous system. With a strong focus on addressing unmet clinical needs, neuropharmacology is expanding the frontiers of science, paving the way for groundbreaking solutions to neurological and psychiatric disorders.
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
George Diaz
Memorial Healthcare Systems, United States
Daniel Curry
Texas Children’s Hospital, United States
Zhenhuan Liu
Guangzhou University Chinese Medicine, China
Kiran Ghotra
Lake Erie College of Osteopathic Medicine, United States
Maryam Golmohammadi
UCLA Doheny Eye Institute, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A Case Report
George Diaz, Memorial Healthcare Systems, United States
Title : What we don’t know about hydrocephalus and It’s management
Daniel Curry, Texas Children’s Hospital, United States
Title : Artificial intelligence-driven DWI and FLAIR for the detection of early stroke changes: A systematic review
Shari L Guerra, The Medical City, Philippines
Title : Mapping neuroplasticity in occupational therapy: Evidence-based interventions with measurable neural outcomes
Jessica Marchant, Texas Woman's University, United States
Title : Non-pharmacologic management of orthostatic hypotension in inpatient rehabilitation: A quality improvement initiative
Laura Steakin, Rehabilitation Institute at Sinai, United States
Title : Non-pharmacologic management of orthostatic hypotension in inpatient rehabilitation: A quality improvement initiative
Mackenzie Weber, Rehabilitation Institute at Sinai, United States